Treating Blood Cancers

By Blood Cancer United

Podcast Series for Professionals by Blood Cancer United... more

4.8

1212 ratings

Download on the App Store

Download on the App Store

Get it on Google Play

FAQs about Treating Blood Cancers:

How many episodes does Treating Blood Cancers have?

The podcast currently has 143 episodes available.

Treating Blood Cancers episodes:

December 17, 2025Delivering Equitable Cancer Care: What Every Healthcare Professional Should Know
Raymond Mailhot, MD, MPH, University of Miami, Miami, FL
Recorded on December 2, 2025

Raymond Mailhot, MD, MPH
Department of Radiation Oncology
University of Miami
Miami, FL
Join us with Dr. Raymond Mailhot from the University of Miami as we explore how social determinants of health shape patient experiences, treatment decisions, and outcomes. He discusses the importance of cultural competence in delivering equitable, patient-centered care and shares practical communication strategies to better engage patients and collaborate effectively. This episode offers actionable insights to strengthen relationships and improve overall care quality. Tune in today to gain practical strategies that will enhance your approach to patient-centered care and drive better outcomes!
Additional Blood Cancer United Resources:
Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education
Blood Cancer United Medical Debt Case Management Program for Patients
Blood Cancer United Additional Resources for Patients
...more
31min
November 20, 2025 Hairy Cell Leukemia: Strategies for Improved Patient Outcomes
Paul J. Hampel, MD, Mayo Clinic, Rochester, MN
Recorded on November 4, 2025

Paul J. Hampel, MD
Assistant Professor of Medicine
Division of Hematology, Department of Medicine
Mayo Clinic
Rochester, MN
In this episode, Dr. Paul Hampel from Mayo Clinic Rochester takes a comprehensive look at hairy cell leukemia (HCL). He reviews the current diagnostic work-up, including immunophenotypic and molecular testing, and highlights key clinical features that distinguish HCL from related disorders. Dr. Hampel also discusses approved frontline therapies and evidence-based approaches for relapsed or refractory disease, with attention to infection risk and supportive care. The conversation explores emerging agents, novel combinations, and clinical trials shaping the next wave of HCL management. Join us for this expert discussion, offering practical insights to enhance care and outcomes for patients with HCL.
...more
41min
November 06, 2025 Managing CML: What HCPs Need to Know
Michael J. Mauro, MD, Memorial Sloan Kettering Cancer Center, New York, NY
Recorded on October 23, 2025

Michael J. Mauro, MD
Director, Chronic Myeloid Leukemia Program
Professor of Medicine, Leukemia Service
Memorial Sloan Kettering Cancer Center
New York, NY
Tune in for this expert-led discussion with Dr. Michael Mauro from Memorial Sloan Kettering Cancer Center on the evolving management of chronic myeloid leukemia (CML) in the era of tyrosine kinase inhibitors (TKIs) and newly approved FDA therapies. Dr. Mauro explores how TKIs have transformed prognosis, key factors guiding initial therapy selection, and best practices for managing treatment-related side effects. He also shares updates on TKI discontinuation criteria, long-term monitoring, and a forward look at ongoing trials and emerging therapeutic advances shaping the future of CML care. Gain actionable insights to enhance patient outcomes today!
...more
38min
October 10, 2025 Understanding MRD: Insights for clinical practice and patient care
Rahul Banerjee, MD, FACP, Fred Hutchinson Cancer Center, Seattle, WA
Recorded on September 25, 2025

Rahul Banerjee, MD, FACP
Assistant Professor
Fred Hutchinson Cancer Center
Seattle, WA
In this episode, Dr. Rahul Banerjee from Fred Hutchinson Cancer Center in Seattle, WA, discusses the evolving role of measurable residual disease (MRD) in hematologic malignancies. He explores what MRD is, how assays are used and interpreted, and its impact across the disease continuum. The conversation also covers MRD’s role in clinical trials, how to effectively explain MRD to patients, practical considerations for testing in community settings, and key education resources for both healthcare professionals and patients. Tune in today to gain practical insights you can apply in your daily practice!
This episode is supported by Adaptive Biotechnologies Corporation and Allogene Therapeutics.
...more
33min
September 19, 2025 Pediatric Acute Leukemias: Focus on clinical trials for treatment
Ann Collins, PA, Blood Cancer United, Washington, DC, Kelly Laschinger, MSN, RN, CPNP, CPHON, Blood Cancer United, Washington, DC, Sarah K. Tasian, MD, Children’s Hospital of Philadelphia, Philadelphia, PA
Recorded on September 9, 2025

Ann Collins, PA
Project Leader, Pediatric Acute Leukemia Master Clinical Trial (PedAL)
Blood Cancer United
Washington, DC
Kelly Laschinger, MSN, RN, CPNP, CPHON
Director, Clinical Trial Support Center
Blood Cancer United
Washington, DC
Sarah K. Tasian, MD
Blood Cancer United PedAL Master Clinical Trial Lead
Associate Professor of Pediatrics, University of Pennsylvania School of Medicine
Chief of Hematologic Malignancies Program, Children’s Hospital of Philadelphia
Philadelphia, PA
Join us for our first episode as Blood Cancer United! In this episode, Dr. Sarah Tasian, from Children’s Hospital of Philadelphia, and Ann Collins and Kelly Laschinger, from Blood Cancer United, join us for an in-depth discussion on pediatric acute leukemias. The conversation delves into the latest therapies, treatment challenges, and the complex realities of long-term survivorship. We also explore the groundbreaking Blood Cancer United Pediatric Acute Leukemia Master Clinical Trial (PedAL), its bold vision, global collaboration, and unified approach to data collection. Valuable clinical trial resources and strategies to support patients, families, and healthcare professionals are also shared. Tune in today!
...more
39min
July 09, 2025 Charting the Course of ALL: From Diagnosis to Advances
Catherine Lai, MD, MPH, University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia, PA
Recorded on June 27, 2025

Catherine Lai, MD, MPH
Associate Professor
Physician Leader, Leukemia Clinical Research Unit
University of Pennsylvania Perelman Center for Advanced Medicine
Philadelphia, PA
In this episode, Dr. Catherine Lai, from the University of Pennsylvania’s Perelman Center for Advanced Medicine, joins us to discuss the current landscape of adult acute lymphoblastic leukemia (ALL) treatment. She highlights recent advances in frontline and relapsed therapies, the critical role of measurable residual disease (MRD), and the use of immunotherapy and targeted treatments. Dr. Lai further explores transplant considerations, management of side effects, and tailored approaches for B-cell and T-cell ALL. She also emphasizes patient-centered care, including strategies for end-of-life discussions and shared decision-making. Tune in today for expert insights and practical takeaways on the evolving future of ALL care!
...more
37min
June 12, 2025 Strategies and Advances in AML
Uma Borate, MBBS, MS, The Ohio State University, Columbus, OH
Recorded on May 27, 2025

Uma Borate, MBBS, MS
Associate Professor, Division of Hematology
Acute Leukemia Clinical Research Disease Group Leader
The Ohio State University
Columbus, OH
What’s changing in acute myeloid leukemia (AML)? Join Dr. Uma Borate from The Ohio State University in Columbus, Ohio, as she dives into emerging breakthroughs in AML biology, including molecular drivers, menin inhibitors, and the challenges of developing bispecifics and CAR T-cell therapies. She also shares updates from the LLS Beat AML® Master Clinical Trial and ongoing clinical trials, and reflects on the evolving treatment landscape across age groups. Don’t miss this dynamic conversation packed with expertise and hope for the future of AML!
...more
39min
May 29, 2025 Advancing Care in Myeloproliferative Neoplasms (MPNs)
Aaron Gerds, MD, MS, Cleveland Clinic, Cleveland, OH
Recorded on May 13, 2025

Aaron Gerds, MD, MS
Associate Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University School of Medicine
Medical Director
Case Comprehensive Cancer Center Clinical Research Office
Cleveland, OH
In this episode, Dr. Aaron Gerds from the Cleveland Clinic explores the intricacies of Myeloproliferative Neoplasms (MPNs), from diagnosis and monitoring to treatment goals and the latest therapeutic advances. Dr. Gerds discusses emerging therapies, the significance of clinical trials, strategies for managing side effects and long-term effects, and valuable resources for healthcare professionals, patients, and families. Tune in today for expert insights on MPNs!
This episode is supported by GSK plc and Karyopharm Therapeutics.
...more
33min
May 13, 2025A Collaborative Approach to Survivorship Care
Tessa Faye Flores, MD, Roswell Park Comprehensive Cancer Center, Buffalo, NY
Recorded on April 24, 2025

Tessa Faye Flores, MD
Medical Director, Cancer Screening and Survivorship
Roswell Park Comprehensive Cancer Center
Buffalo, NY
We are pleased to celebrate the 100th episode of Treating Blood Cancers with Dr. Tessa Flores from Roswell Park Comprehensive Cancer Center in Buffalo, New York, as she shares insights into survivorship care. In this episode, Dr. Flores explores the different phases of survivorship and the psychosocial challenges that accompany each stage. She highlights the vital role of a collaborative care team, including primary care practitioners, in supporting survivors of cancer to achieve and maintain a healthy post-treatment life. As the number of survivors continues to grow, the focus on long-term wellness becomes increasingly important. Dr. Flores emphasizes, “A tenet of survivorship care is preventive care”. Tune in for this special episode and join the conversation today!
This episode is supported by Genentech, A Member of the Roche Group.
Additional Episodes on Survivorship Care:
Key Strategies for HCPs: Supporting Caregivers and Care Partners
Understanding Mental Health in Cancer Survivorship
Navigating Adult Survivorship Care
Exploring Survivorship Needs of Older Adults
Strategic Approaches to Pediatric and AYA Survivorship Care
Creating a Roadmap for Adult Survivorship Care
Survivorship Care of Older Adults: Addressing the Unique Needs
Supporting Adolescent and Young Adult (AYA) Survivors
A Conversation on Adult Survivorship
...more
33min
April 30, 2025 MDS: Patient-Centered Approaches to Diagnosis and Treatment
Mikkael A. Sekeres, MD, MS, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL
Recorded on April 17, 2025

Mikkael A. Sekeres, MD, MS
Chief, Division of Hematology
Professor of Medicine
Sylvester Comprehensive Cancer Center
University of Miami
Miami, FL
Join us with Dr. Mikkael Sekeres of the University of Miami Sylvester Comprehensive Cancer Center as he explores the complexities of diagnosing and treating Myelodysplastic Syndromes (MDS), including “watch and wait.” Through case-based discussion, he highlights advances in high-risk MDS management, from novel targeted therapies to stem cell transplantation and clinical trials. Dr. Sekeres also shares strategies for managing side effects and emphasizes the importance of multidisciplinary care in improving patient outcomes. Tune in to gain valuable insights on MDS today!
...more
43min

FAQs about Treating Blood Cancers:

How many episodes does Treating Blood Cancers have?

The podcast currently has 143 episodes available.

More shows like Treating Blood Cancers

Hidden Brain by Hidden Brain, Shankar Vedantam

Hidden Brain

43,588 Listeners

NEJM This Week by NEJM Group

NEJM This Week

320 Listeners

The Curbsiders Internal Medicine Podcast by The Curbsiders Internal Medicine Podcast

The Curbsiders Internal Medicine Podcast

3,351 Listeners

Up First from NPR by NPR

Up First from NPR

56,525 Listeners

The Bloodline with Blood Cancer United Podcast by Blood Cancer United

The Bloodline with Blood Cancer United Podcast

46 Listeners

Core IM | Internal Medicine Podcast by Core IM Team

Core IM | Internal Medicine Podcast

1,147 Listeners

The ONS Podcast by Oncology Nursing Society

The ONS Podcast

206 Listeners

OncoPharm by John Bossaer

OncoPharm

187 Listeners

OncLive® On Air by OncLive® On Air

OncLive® On Air

22 Listeners

Blood Podcast by American Society of Hematology

Blood Podcast

52 Listeners

ASTCT Talks by ASTCT

ASTCT Talks

8 Listeners

The Mel Robbins Podcast by Mel Robbins

The Mel Robbins Podcast

19,668 Listeners

Blood Cancer Talks by Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff

Blood Cancer Talks

48 Listeners

Oncology Brothers: Practice-Changing Cancer Discussions by Oncology Brothers

Oncology Brothers: Practice-Changing Cancer Discussions

44 Listeners

WolverHeme Happy Hour by Bernard Marini, Anthony Perissinotti, et al.

WolverHeme Happy Hour

31 Listeners